DBV Technologies S.A. (DBVT) is a publicly traded Healthcare sector company. As of May 20, 2026, DBVT trades at $18.49 with a market cap of $1.11B and a P/E ratio of -17.67. DBVT moved +0.49% today. Year to date, DBVT is +9.12%; over the trailing twelve months it is +93.13%. Its 52-week range spans $2.20 to $26.19. Analyst consensus is buy with an average price target of $40.97. Rallies surfaces DBVT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
DBV Technologies S.A. (DBVT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. DBVT moved +0.49% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $18.49 |
| Market Cap | $1.11B |
| P/E Ratio | -17.67 |
| EPS | $-1.05 |
| Dividend Yield | 0.00% |
| 52-Week High | $26.19 |
| 52-Week Low | $2.20 |
| Volume | 103.27K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.64M |
| Net Income | $-146.95M |
| Gross Margin | 0.00% |
6 analysts cover DBVT: 0 strong buy, 5 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $40.97.